Grant Detail
The grant detail shows the name of the PI, active dates of the project, the funding institute and the abstract of the grant. This abstract is what is used to create the fingerprint of the grant. If any publications referencing this grant are found in the data, they will be listed here as well.
Hypoglycemia Associated Autonomic Failure in Type 1 DM
30 September 2004 - 30 June 2009
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
Intensive glycemic control reduces the onset and slows the progression of microvascular complications in patients with type 1 diabetes (T1DM). Unfortunately, the major obstacle preventing the goal of euglycemia in T1DM is the associated three-fold increase in severe hypoglycemia. Many studies have identified acquired failure of neuroendocrine and in particular autonomic nervous system (ANS), counterregulatory responses as a cause of the increased prevalence of hypoglycemia occurring in intensively treated T1DM. Central to the development of the acquired ANS failure are prior episodes of hypoglycemia. The mechanisms responsible for prior hypoglycemia resulting in acquired ANS and neuroendocrine failure during subsequent hypoglycemia need to be determined. During the last several years, there has been a growing interest in the role played by cerebral mechanisms in regulating ANS and neuroendocrine responses during hypoglycemia. Brain corticosteroid and gamma-aminobutyric acid (A) (GABA (A)) receptors are known to exert inhibitory influences on ANS and neuroendocrine function. We hypothesize that activation of brain corticosteroid (type 1 MR and/or type 2 GR) and/or GABA (A) receptors by prior hypoglycemia may be important mechanisms responsible for the blunted ANS and neuroendocrine counterregulatory responses occurring in intensively treated T1DM patients. Currently, there are no readily available adjunct treatments that protect the ANS from the deleterious effects of repeated hypoglycemia. In this proposal, we will conduct experiments to determine whether the adrenal hormone dihydroepiandrostenedione-sulfate (DHEAS) which has recognized anticorticosteroid and anti GABA (A) receptor activity may preserve ANS function during prior episodes of hypoglycemia in T1DM. Both antecedent episodes of hypoglycemia and exercise can blunt epinephrine responses during subsequent episodes of hypoglycemia. However, it is unknown whether episodes of hypoglycemia and/or exercise will also reduce the physiologic actions of this key hormone in intensively treated T1DM patients. This information is needed as treatment strategies, aimed at increasing epinephrine responses during hypoglycemia in T1DM, will have limited effectiveness if target organs are unresponsive. The studies outlined in this proposal are therefore focused at determining the in-vivo mechanisms regulating ANS counterregulatory failure during hypoglycemia in T1DM humans. Experiments will use the glucose clamp technique. ANS responses to hypoglycemia will be assessed by measuring circulating catecholamines, pancreatic polypeptide, muscle sympathetic nerve activity, symptom scores, and heart rate variability. Neuroendocrine responses will be determined by measuring growth hormone, cortisol and ACTH. Metabolic counterregulatory mechanisms will be determined by measuring glucose and glycerol turnover, skeletal muscle metabolism with muscle biopsies, substrate levels, and substrate oxidation via indirect calorimetry. The specific aims of this proposal are to determine: 1) the roles played by gamma aminobutyric acid (GABA (A)) and corticosteroid receptors in the development of hypoglycemia associated autonomic failure in type 1 diabetes, 2) if dihydroepiandrostenedione-sulfate can prevent hypoglycemia associated autonomic failure in type 1 diabetic man, 3) if prior hypoglycemia and/or exercise blunts subsequent metabolic/cardiovascular responses to epinephrine in type 1 diabetic man, and 4) if selective serotonin reuptake inhibitors blunt counterregulatory responses to hypoglycemia in type 1 DM man.
12 Resulting Publications
-
1.
2011Lisa M Younk; Stephen N Davis
Hypoglycemia and vascular disease.
Clinical chemistry 2011;57(2):258-60. -
2.
2010Nino Gogitidze Joy; Maka S Hedrington; Vanessa J Briscoe; Donna B Tate; Andrew C Ertl; Stephen N Davis
Diabetes care 2010;33(7):1529-35. -
3.
2010Maka S Hedrington; Stephnie Farmerie; Andrew C Ertl; Zhihui Wang; Donna B Tate; Stephen N Davis
Diabetes 2010;59(4):1074-81. -
4.
2009Shichun Bao; Vanessa J Briscoe; Donna B Tate; Stephen N Davis
Diabetes 2009;58(9):2100-8. -
5.
2009Stephen N Davis; Stephanie Mann; Vanessa J Briscoe; Andrew C Ertl; Donna B Tate
Diabetes 2009;58(3):701-9. -
6.
2008Vanessa J Briscoe; Andrew C Ertl; Donna B Tate; Stephen N Davis
Diabetes 2008;57(12):3315-22. -
7.
2008Vanessa J Briscoe; Andrew C Ertl; Donna B Tate; Sheila Dawling; Stephen N Davis
Diabetes 2008;57(9):2453-60. -
8.
2008Andrew C Ertl; Stephnie Mann; Antoinette Richardson; Vanessa J Briscoe; Hannah B Blair; Donna B Tate; Stephen N Davis
American journal of physiology. Endocrinology and metabolism 2008;295(3):E618-25. -
9.
2008Stephanie M Gustavson; Darleen A Sandoval; Andrew C Ertl; Shichun Bao; Satish R Raj; Stephen N Davis
American journal of physiology. Endocrinology and metabolism 2008;294(3):E506-12. -
10.
2007Darleen A Sandoval; Bin Gong; Stephen N Davis
American journal of physiology. Endocrinology and metabolism 2007;293(6):E1511-6. -
11.
2007Stephen N Davis; Jennifer M Perkins
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2007;13(7):790-804. -
12.
2007Vanessa Jones Briscoe; Donna Bowman Tate; Stephen Neil Davis
Type 1 diabetes: exercise and hypoglycemia.
Applied physiology, nutrition, and metabolism = Physiologie appliquée, nutrition et métabolisme 2007;32(3):576-82.
Scientific Context
This section shows information that has been computed by using the fingerprint of the grant, including related publications, related experts and related grants - all with fingerprints representing significant amounts of overlap between their fingerprint and this grant. The red dots indicate whether those experts or terms actually appear within this grant, showing potential and actual connections.
Related Grants
-
1.
Berman, Brian M
Functional Bowel Disorders in Chinese Medicine
30 September 2005 - 29 September 2009
NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE
-
2.
Devoe, Don L
Proteomics of Cell Death via 2-D Micorfluidic Profiling
15 September 2005 - 31 August 2009
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
-
3.
Blanchard, Thomas G
H. PYLORI-SPECIFIC REGULATORY T CELLS THAT LIMIT HOST RESPONSE
1 February 2004 - 31 January 2009
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Related Publications
-
1.
2008Andrew C Ertl; Stephnie Mann; Antoinette Richardson; Vanessa J Briscoe; Hannah B Blair; Donna B Tate; Stephen N Davis
American journal of physiology. Endocrinology and metabolism 2008;295(3):E618-25. -
2.
2005Deanna Aftab Guy; Darleen Sandoval; M A Richardson; Donna Tate; Paul J Flakoll; Stephen N Davis
Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans.
American journal of physiology. Endocrinology and metabolism 2005;288(1):E178-86. -
3.
2004Pietro Galassetti; Donna Tate; Ray A Neill; Sachiko Morrey; David H Wasserman; Stephen N Davis
American journal of physiology. Endocrinology and metabolism 2004;287(1):E16-24.

Appears in this Publication







